nodes	percent_of_prediction	percent_of_DWPC	metapath
Delavirdine—CYP1A2—Carmustine—lymphatic system cancer	0.117	0.168	CbGbCtD
Delavirdine—CYP3A5—Teniposide—lymphatic system cancer	0.106	0.152	CbGbCtD
Delavirdine—CYP2C19—Teniposide—lymphatic system cancer	0.0853	0.122	CbGbCtD
Delavirdine—CYP2C9—Teniposide—lymphatic system cancer	0.0709	0.102	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0678	0.0973	CbGbCtD
Delavirdine—CYP3A7—Vincristine—lymphatic system cancer	0.0678	0.0973	CbGbCtD
Delavirdine—CYP3A5—Vincristine—lymphatic system cancer	0.0509	0.073	CbGbCtD
Delavirdine—CYP3A4—Cytarabine—lymphatic system cancer	0.0419	0.06	CbGbCtD
Delavirdine—CYP3A4—Teniposide—lymphatic system cancer	0.0412	0.0591	CbGbCtD
Delavirdine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0288	0.0414	CbGbCtD
Delavirdine—CYP3A4—Vincristine—lymphatic system cancer	0.0198	0.0285	CbGbCtD
Delavirdine—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00046	0.00152	CcSEcCtD
Delavirdine—Anaemia—Bleomycin—lymphatic system cancer	0.00046	0.00152	CcSEcCtD
Delavirdine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000456	0.00151	CcSEcCtD
Delavirdine—Asthenia—Teniposide—lymphatic system cancer	0.000452	0.00149	CcSEcCtD
Delavirdine—Malaise—Bleomycin—lymphatic system cancer	0.000448	0.00148	CcSEcCtD
Delavirdine—Pruritus—Teniposide—lymphatic system cancer	0.000445	0.00147	CcSEcCtD
Delavirdine—Leukopenia—Bleomycin—lymphatic system cancer	0.000445	0.00147	CcSEcCtD
Delavirdine—Alopecia—Carmustine—lymphatic system cancer	0.000441	0.00146	CcSEcCtD
Delavirdine—Skin exfoliation—Methotrexate—lymphatic system cancer	0.000439	0.00145	CcSEcCtD
Delavirdine—Body temperature increased—Fludarabine—lymphatic system cancer	0.000437	0.00145	CcSEcCtD
Delavirdine—Malnutrition—Carmustine—lymphatic system cancer	0.000434	0.00143	CcSEcCtD
Delavirdine—Erythema—Carmustine—lymphatic system cancer	0.000434	0.00143	CcSEcCtD
Delavirdine—Cough—Bleomycin—lymphatic system cancer	0.000434	0.00143	CcSEcCtD
Delavirdine—Diarrhoea—Teniposide—lymphatic system cancer	0.000431	0.00142	CcSEcCtD
Delavirdine—Chest pain—Bleomycin—lymphatic system cancer	0.000423	0.0014	CcSEcCtD
Delavirdine—Myalgia—Bleomycin—lymphatic system cancer	0.000423	0.0014	CcSEcCtD
Delavirdine—Alopecia—Vincristine—lymphatic system cancer	0.000421	0.00139	CcSEcCtD
Delavirdine—Back pain—Carmustine—lymphatic system cancer	0.00042	0.00139	CcSEcCtD
Delavirdine—Discomfort—Bleomycin—lymphatic system cancer	0.000418	0.00138	CcSEcCtD
Delavirdine—Chills—Mitoxantrone—lymphatic system cancer	0.000416	0.00137	CcSEcCtD
Delavirdine—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000416	0.00137	CcSEcCtD
Delavirdine—Urine output increased—Methotrexate—lymphatic system cancer	0.000416	0.00137	CcSEcCtD
Delavirdine—Ecchymosis—Methotrexate—lymphatic system cancer	0.000416	0.00137	CcSEcCtD
Delavirdine—Alopecia—Mitoxantrone—lymphatic system cancer	0.00041	0.00135	CcSEcCtD
Delavirdine—Confusional state—Bleomycin—lymphatic system cancer	0.000409	0.00135	CcSEcCtD
Delavirdine—Vision blurred—Carmustine—lymphatic system cancer	0.000409	0.00135	CcSEcCtD
Delavirdine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000408	0.00135	CcSEcCtD
Delavirdine—Tremor—Carmustine—lymphatic system cancer	0.000407	0.00134	CcSEcCtD
Delavirdine—Oedema—Bleomycin—lymphatic system cancer	0.000406	0.00134	CcSEcCtD
Delavirdine—Erythema—Mitoxantrone—lymphatic system cancer	0.000403	0.00133	CcSEcCtD
Delavirdine—Infection—Bleomycin—lymphatic system cancer	0.000403	0.00133	CcSEcCtD
Delavirdine—Anaemia—Carmustine—lymphatic system cancer	0.000401	0.00133	CcSEcCtD
Delavirdine—Back pain—Vincristine—lymphatic system cancer	0.000401	0.00132	CcSEcCtD
Delavirdine—Vomiting—Teniposide—lymphatic system cancer	0.0004	0.00132	CcSEcCtD
Delavirdine—Agitation—Carmustine—lymphatic system cancer	0.000399	0.00132	CcSEcCtD
Delavirdine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000397	0.00131	CcSEcCtD
Delavirdine—Asthenia—Fludarabine—lymphatic system cancer	0.000397	0.00131	CcSEcCtD
Delavirdine—Rash—Teniposide—lymphatic system cancer	0.000397	0.00131	CcSEcCtD
Delavirdine—Dermatitis—Teniposide—lymphatic system cancer	0.000397	0.00131	CcSEcCtD
Delavirdine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000395	0.00131	CcSEcCtD
Delavirdine—Headache—Teniposide—lymphatic system cancer	0.000394	0.0013	CcSEcCtD
Delavirdine—Pruritus—Fludarabine—lymphatic system cancer	0.000392	0.00129	CcSEcCtD
Delavirdine—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000391	0.00129	CcSEcCtD
Delavirdine—Back pain—Mitoxantrone—lymphatic system cancer	0.00039	0.00129	CcSEcCtD
Delavirdine—Leukopenia—Carmustine—lymphatic system cancer	0.000388	0.00128	CcSEcCtD
Delavirdine—Anorexia—Bleomycin—lymphatic system cancer	0.000387	0.00128	CcSEcCtD
Delavirdine—Anaemia—Vincristine—lymphatic system cancer	0.000383	0.00127	CcSEcCtD
Delavirdine—Agitation—Vincristine—lymphatic system cancer	0.000381	0.00126	CcSEcCtD
Delavirdine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00038	0.00126	CcSEcCtD
Delavirdine—Polyuria—Methotrexate—lymphatic system cancer	0.00038	0.00126	CcSEcCtD
Delavirdine—Hypotension—Bleomycin—lymphatic system cancer	0.000379	0.00125	CcSEcCtD
Delavirdine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000379	0.00125	CcSEcCtD
Delavirdine—Hypertension—Carmustine—lymphatic system cancer	0.000375	0.00124	CcSEcCtD
Delavirdine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000374	0.00124	CcSEcCtD
Delavirdine—Nausea—Teniposide—lymphatic system cancer	0.000374	0.00124	CcSEcCtD
Delavirdine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000373	0.00123	CcSEcCtD
Delavirdine—Vertigo—Vincristine—lymphatic system cancer	0.000372	0.00123	CcSEcCtD
Delavirdine—Hepatic failure—Methotrexate—lymphatic system cancer	0.000371	0.00123	CcSEcCtD
Delavirdine—Leukopenia—Vincristine—lymphatic system cancer	0.000371	0.00123	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00037	0.00122	CcSEcCtD
Delavirdine—Chest pain—Carmustine—lymphatic system cancer	0.000369	0.00122	CcSEcCtD
Delavirdine—Myalgia—Carmustine—lymphatic system cancer	0.000369	0.00122	CcSEcCtD
Delavirdine—Anxiety—Carmustine—lymphatic system cancer	0.000368	0.00122	CcSEcCtD
Delavirdine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000364	0.0012	CcSEcCtD
Delavirdine—Malaise—Mitoxantrone—lymphatic system cancer	0.000364	0.0012	CcSEcCtD
Delavirdine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000362	0.0012	CcSEcCtD
Delavirdine—Renal failure acute—Methotrexate—lymphatic system cancer	0.000362	0.00119	CcSEcCtD
Delavirdine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000361	0.00119	CcSEcCtD
Delavirdine—Hypertension—Vincristine—lymphatic system cancer	0.000358	0.00118	CcSEcCtD
Delavirdine—Confusional state—Carmustine—lymphatic system cancer	0.000357	0.00118	CcSEcCtD
Delavirdine—Oedema—Carmustine—lymphatic system cancer	0.000354	0.00117	CcSEcCtD
Delavirdine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000354	0.00117	CcSEcCtD
Delavirdine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000353	0.00117	CcSEcCtD
Delavirdine—Myalgia—Vincristine—lymphatic system cancer	0.000353	0.00117	CcSEcCtD
Delavirdine—Cough—Mitoxantrone—lymphatic system cancer	0.000352	0.00116	CcSEcCtD
Delavirdine—Infection—Carmustine—lymphatic system cancer	0.000352	0.00116	CcSEcCtD
Delavirdine—Vomiting—Fludarabine—lymphatic system cancer	0.000352	0.00116	CcSEcCtD
Delavirdine—Rash—Fludarabine—lymphatic system cancer	0.000349	0.00115	CcSEcCtD
Delavirdine—Dermatitis—Fludarabine—lymphatic system cancer	0.000349	0.00115	CcSEcCtD
Delavirdine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000348	0.00115	CcSEcCtD
Delavirdine—Pain—Bleomycin—lymphatic system cancer	0.000347	0.00115	CcSEcCtD
Delavirdine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000347	0.00115	CcSEcCtD
Delavirdine—Headache—Fludarabine—lymphatic system cancer	0.000347	0.00115	CcSEcCtD
Delavirdine—Tachycardia—Carmustine—lymphatic system cancer	0.000346	0.00114	CcSEcCtD
Delavirdine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000343	0.00113	CcSEcCtD
Delavirdine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000343	0.00113	CcSEcCtD
Delavirdine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000343	0.00113	CcSEcCtD
Delavirdine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000342	0.00113	CcSEcCtD
Delavirdine—Lethargy—Methotrexate—lymphatic system cancer	0.000341	0.00113	CcSEcCtD
Delavirdine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000339	0.00112	CcSEcCtD
Delavirdine—Oedema—Vincristine—lymphatic system cancer	0.000338	0.00112	CcSEcCtD
Delavirdine—Anorexia—Carmustine—lymphatic system cancer	0.000338	0.00112	CcSEcCtD
Delavirdine—Infection—Vincristine—lymphatic system cancer	0.000336	0.00111	CcSEcCtD
Delavirdine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000334	0.0011	CcSEcCtD
Delavirdine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000332	0.0011	CcSEcCtD
Delavirdine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000331	0.00109	CcSEcCtD
Delavirdine—Hypotension—Carmustine—lymphatic system cancer	0.000331	0.00109	CcSEcCtD
Delavirdine—Oedema—Mitoxantrone—lymphatic system cancer	0.000329	0.00109	CcSEcCtD
Delavirdine—Nausea—Fludarabine—lymphatic system cancer	0.000329	0.00109	CcSEcCtD
Delavirdine—Infection—Mitoxantrone—lymphatic system cancer	0.000327	0.00108	CcSEcCtD
Delavirdine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000327	0.00108	CcSEcCtD
Delavirdine—Shock—Mitoxantrone—lymphatic system cancer	0.000324	0.00107	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000323	0.00107	CcSEcCtD
Delavirdine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000322	0.00107	CcSEcCtD
Delavirdine—Urticaria—Bleomycin—lymphatic system cancer	0.000322	0.00107	CcSEcCtD
Delavirdine—Anorexia—Vincristine—lymphatic system cancer	0.000322	0.00106	CcSEcCtD
Delavirdine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000321	0.00106	CcSEcCtD
Delavirdine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000321	0.00106	CcSEcCtD
Delavirdine—Insomnia—Carmustine—lymphatic system cancer	0.00032	0.00106	CcSEcCtD
Delavirdine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00032	0.00106	CcSEcCtD
Delavirdine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000318	0.00105	CcSEcCtD
Delavirdine—Paraesthesia—Carmustine—lymphatic system cancer	0.000318	0.00105	CcSEcCtD
Delavirdine—Mood swings—Methotrexate—lymphatic system cancer	0.000316	0.00104	CcSEcCtD
Delavirdine—Hypotension—Vincristine—lymphatic system cancer	0.000316	0.00104	CcSEcCtD
Delavirdine—Dyspnoea—Carmustine—lymphatic system cancer	0.000316	0.00104	CcSEcCtD
Delavirdine—Somnolence—Carmustine—lymphatic system cancer	0.000315	0.00104	CcSEcCtD
Delavirdine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000314	0.00104	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000308	0.00102	CcSEcCtD
Delavirdine—Decreased appetite—Carmustine—lymphatic system cancer	0.000308	0.00102	CcSEcCtD
Delavirdine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000308	0.00102	CcSEcCtD
Delavirdine—Insomnia—Vincristine—lymphatic system cancer	0.000306	0.00101	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000306	0.00101	CcSEcCtD
Delavirdine—Paraesthesia—Vincristine—lymphatic system cancer	0.000304	0.001	CcSEcCtD
Delavirdine—Pain—Carmustine—lymphatic system cancer	0.000303	0.001	CcSEcCtD
Delavirdine—Constipation—Carmustine—lymphatic system cancer	0.000303	0.001	CcSEcCtD
Delavirdine—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000301	0.000993	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.0003	0.000991	CcSEcCtD
Delavirdine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000299	0.000988	CcSEcCtD
Delavirdine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000296	0.000977	CcSEcCtD
Delavirdine—Decreased appetite—Vincristine—lymphatic system cancer	0.000294	0.000971	CcSEcCtD
Delavirdine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000294	0.00097	CcSEcCtD
Delavirdine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000293	0.000967	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000292	0.000964	CcSEcCtD
Delavirdine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000292	0.000964	CcSEcCtD
Delavirdine—Fatigue—Vincristine—lymphatic system cancer	0.000291	0.000963	CcSEcCtD
Delavirdine—Asthenia—Bleomycin—lymphatic system cancer	0.000291	0.000962	CcSEcCtD
Delavirdine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00029	0.000958	CcSEcCtD
Delavirdine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00029	0.000957	CcSEcCtD
Delavirdine—Pain—Vincristine—lymphatic system cancer	0.000289	0.000955	CcSEcCtD
Delavirdine—Constipation—Vincristine—lymphatic system cancer	0.000289	0.000955	CcSEcCtD
Delavirdine—Pruritus—Bleomycin—lymphatic system cancer	0.000287	0.000948	CcSEcCtD
Delavirdine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000286	0.000946	CcSEcCtD
Delavirdine—Eosinophilia—Methotrexate—lymphatic system cancer	0.000286	0.000944	CcSEcCtD
Delavirdine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000284	0.000938	CcSEcCtD
Delavirdine—Pancreatitis—Methotrexate—lymphatic system cancer	0.000283	0.000935	CcSEcCtD
Delavirdine—Pain—Mitoxantrone—lymphatic system cancer	0.000282	0.00093	CcSEcCtD
Delavirdine—Constipation—Mitoxantrone—lymphatic system cancer	0.000282	0.00093	CcSEcCtD
Delavirdine—Abdominal pain—Carmustine—lymphatic system cancer	0.00028	0.000925	CcSEcCtD
Delavirdine—Body temperature increased—Carmustine—lymphatic system cancer	0.00028	0.000925	CcSEcCtD
Delavirdine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000276	0.000913	CcSEcCtD
Delavirdine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000274	0.000905	CcSEcCtD
Delavirdine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000271	0.000896	CcSEcCtD
Delavirdine—Neutropenia—Methotrexate—lymphatic system cancer	0.00027	0.000891	CcSEcCtD
Delavirdine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000269	0.00089	CcSEcCtD
Delavirdine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000268	0.000886	CcSEcCtD
Delavirdine—Abdominal pain—Vincristine—lymphatic system cancer	0.000267	0.000883	CcSEcCtD
Delavirdine—Body temperature increased—Vincristine—lymphatic system cancer	0.000267	0.000883	CcSEcCtD
Delavirdine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000266	0.000878	CcSEcCtD
Delavirdine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000262	0.000864	CcSEcCtD
Delavirdine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000261	0.000862	CcSEcCtD
Delavirdine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00026	0.00086	CcSEcCtD
Delavirdine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00026	0.00086	CcSEcCtD
Delavirdine—Pneumonia—Methotrexate—lymphatic system cancer	0.000259	0.000855	CcSEcCtD
Delavirdine—Vomiting—Bleomycin—lymphatic system cancer	0.000258	0.000852	CcSEcCtD
Delavirdine—Rash—Bleomycin—lymphatic system cancer	0.000256	0.000845	CcSEcCtD
Delavirdine—Dermatitis—Bleomycin—lymphatic system cancer	0.000256	0.000845	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000255	0.000843	CcSEcCtD
Delavirdine—Asthenia—Carmustine—lymphatic system cancer	0.000254	0.00084	CcSEcCtD
Delavirdine—Stomatitis—Methotrexate—lymphatic system cancer	0.000251	0.000828	CcSEcCtD
Delavirdine—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00025	0.000826	CcSEcCtD
Delavirdine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000249	0.000823	CcSEcCtD
Delavirdine—Haematuria—Methotrexate—lymphatic system cancer	0.000245	0.00081	CcSEcCtD
Delavirdine—Epistaxis—Methotrexate—lymphatic system cancer	0.000243	0.000802	CcSEcCtD
Delavirdine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000243	0.000802	CcSEcCtD
Delavirdine—Asthenia—Vincristine—lymphatic system cancer	0.000243	0.000801	CcSEcCtD
Delavirdine—Diarrhoea—Carmustine—lymphatic system cancer	0.000242	0.000801	CcSEcCtD
Delavirdine—Nausea—Bleomycin—lymphatic system cancer	0.000241	0.000796	CcSEcCtD
Delavirdine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000236	0.000781	CcSEcCtD
Delavirdine—Dizziness—Carmustine—lymphatic system cancer	0.000234	0.000774	CcSEcCtD
Delavirdine—Diarrhoea—Vincristine—lymphatic system cancer	0.000231	0.000764	CcSEcCtD
Delavirdine—Hepatitis—Methotrexate—lymphatic system cancer	0.000231	0.000763	CcSEcCtD
Delavirdine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000229	0.000757	CcSEcCtD
Delavirdine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000225	0.000744	CcSEcCtD
Delavirdine—Vomiting—Carmustine—lymphatic system cancer	0.000225	0.000744	CcSEcCtD
Delavirdine—Dizziness—Vincristine—lymphatic system cancer	0.000224	0.000739	CcSEcCtD
Delavirdine—Rash—Carmustine—lymphatic system cancer	0.000223	0.000738	CcSEcCtD
Delavirdine—Dermatitis—Carmustine—lymphatic system cancer	0.000223	0.000737	CcSEcCtD
Delavirdine—Headache—Carmustine—lymphatic system cancer	0.000222	0.000733	CcSEcCtD
Delavirdine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000218	0.000721	CcSEcCtD
Delavirdine—Tinnitus—Methotrexate—lymphatic system cancer	0.000215	0.000711	CcSEcCtD
Delavirdine—Vomiting—Vincristine—lymphatic system cancer	0.000215	0.00071	CcSEcCtD
Delavirdine—Rash—Vincristine—lymphatic system cancer	0.000213	0.000704	CcSEcCtD
Delavirdine—Dermatitis—Vincristine—lymphatic system cancer	0.000213	0.000704	CcSEcCtD
Delavirdine—Headache—Vincristine—lymphatic system cancer	0.000212	0.0007	CcSEcCtD
Delavirdine—Nausea—Carmustine—lymphatic system cancer	0.00021	0.000695	CcSEcCtD
Delavirdine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000209	0.000692	CcSEcCtD
Delavirdine—Rash—Mitoxantrone—lymphatic system cancer	0.000208	0.000686	CcSEcCtD
Delavirdine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000207	0.000685	CcSEcCtD
Delavirdine—Chills—Methotrexate—lymphatic system cancer	0.000207	0.000685	CcSEcCtD
Delavirdine—Headache—Mitoxantrone—lymphatic system cancer	0.000206	0.000682	CcSEcCtD
Delavirdine—Alopecia—Methotrexate—lymphatic system cancer	0.000204	0.000674	CcSEcCtD
Delavirdine—Malnutrition—Methotrexate—lymphatic system cancer	0.000201	0.000664	CcSEcCtD
Delavirdine—Erythema—Methotrexate—lymphatic system cancer	0.000201	0.000664	CcSEcCtD
Delavirdine—Nausea—Vincristine—lymphatic system cancer	0.000201	0.000664	CcSEcCtD
Delavirdine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000197	0.00065	CcSEcCtD
Delavirdine—Nausea—Mitoxantrone—lymphatic system cancer	0.000196	0.000646	CcSEcCtD
Delavirdine—Back pain—Methotrexate—lymphatic system cancer	0.000194	0.000642	CcSEcCtD
Delavirdine—Vision blurred—Methotrexate—lymphatic system cancer	0.000189	0.000626	CcSEcCtD
Delavirdine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000187	0.000616	CcSEcCtD
Delavirdine—Anaemia—Methotrexate—lymphatic system cancer	0.000186	0.000614	CcSEcCtD
Delavirdine—Malaise—Methotrexate—lymphatic system cancer	0.000181	0.000599	CcSEcCtD
Delavirdine—Vertigo—Methotrexate—lymphatic system cancer	0.000181	0.000597	CcSEcCtD
Delavirdine—Leukopenia—Methotrexate—lymphatic system cancer	0.00018	0.000594	CcSEcCtD
Delavirdine—Cough—Methotrexate—lymphatic system cancer	0.000175	0.00058	CcSEcCtD
Delavirdine—Arthralgia—Methotrexate—lymphatic system cancer	0.000171	0.000565	CcSEcCtD
Delavirdine—Myalgia—Methotrexate—lymphatic system cancer	0.000171	0.000565	CcSEcCtD
Delavirdine—Chest pain—Methotrexate—lymphatic system cancer	0.000171	0.000565	CcSEcCtD
Delavirdine—Discomfort—Methotrexate—lymphatic system cancer	0.000169	0.000559	CcSEcCtD
Delavirdine—Confusional state—Methotrexate—lymphatic system cancer	0.000165	0.000547	CcSEcCtD
Delavirdine—Infection—Methotrexate—lymphatic system cancer	0.000163	0.000538	CcSEcCtD
Delavirdine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000161	0.000531	CcSEcCtD
Delavirdine—Skin disorder—Methotrexate—lymphatic system cancer	0.000159	0.000526	CcSEcCtD
Delavirdine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000159	0.000524	CcSEcCtD
Delavirdine—Anorexia—Methotrexate—lymphatic system cancer	0.000156	0.000517	CcSEcCtD
Delavirdine—Hypotension—Methotrexate—lymphatic system cancer	0.000153	0.000506	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000149	0.000494	CcSEcCtD
Delavirdine—Insomnia—Methotrexate—lymphatic system cancer	0.000148	0.00049	CcSEcCtD
Delavirdine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000147	0.000487	CcSEcCtD
Delavirdine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000146	0.000483	CcSEcCtD
Delavirdine—Somnolence—Methotrexate—lymphatic system cancer	0.000146	0.000482	CcSEcCtD
Delavirdine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000144	0.000477	CcSEcCtD
Delavirdine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000143	0.000471	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000142	0.000468	CcSEcCtD
Delavirdine—Fatigue—Methotrexate—lymphatic system cancer	0.000141	0.000467	CcSEcCtD
Delavirdine—Pain—Methotrexate—lymphatic system cancer	0.00014	0.000464	CcSEcCtD
Delavirdine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000135	0.000447	CcSEcCtD
Delavirdine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000134	0.000443	CcSEcCtD
Delavirdine—Urticaria—Methotrexate—lymphatic system cancer	0.00013	0.000431	CcSEcCtD
Delavirdine—Abdominal pain—Methotrexate—lymphatic system cancer	0.00013	0.000428	CcSEcCtD
Delavirdine—Body temperature increased—Methotrexate—lymphatic system cancer	0.00013	0.000428	CcSEcCtD
Delavirdine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000121	0.000399	CcSEcCtD
Delavirdine—Asthenia—Methotrexate—lymphatic system cancer	0.000118	0.000389	CcSEcCtD
Delavirdine—Pruritus—Methotrexate—lymphatic system cancer	0.000116	0.000383	CcSEcCtD
Delavirdine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000112	0.000371	CcSEcCtD
Delavirdine—Dizziness—Methotrexate—lymphatic system cancer	0.000108	0.000358	CcSEcCtD
Delavirdine—Vomiting—Methotrexate—lymphatic system cancer	0.000104	0.000345	CcSEcCtD
Delavirdine—Rash—Methotrexate—lymphatic system cancer	0.000103	0.000342	CcSEcCtD
Delavirdine—Dermatitis—Methotrexate—lymphatic system cancer	0.000103	0.000341	CcSEcCtD
Delavirdine—Headache—Methotrexate—lymphatic system cancer	0.000103	0.00034	CcSEcCtD
Delavirdine—Nausea—Methotrexate—lymphatic system cancer	9.74e-05	0.000322	CcSEcCtD
